The American Association of Clinical Endocrinologists (AACE) recently wrapped up its annual meeting (May 16–20). Nearly 3,000 clinicians convened in Boston, MA to partake in “Charting the Future of Endocrinology” — the theme for this year’s meeting.
AACE is the place for all of the latest research in Endocrinology…
Harmine can induce beta cell regeneration. #AACE2018 The way they found this reminds me of Edison discovering The right filament for __ light bulbs. pic.twitter.com/E7D9mxkhPh
— Johnson Thomas (@JohnsonThomasMD) May 18, 2018
Including new guidelines…
Guidelines for lipid lowering Tx. Important to keep CKD in mind. #cholesterol #statins #AACE2018 #ClinicalEndoStrong pic.twitter.com/A94SAaF2Qp
— Aaron R.Chidakel, MD (@ACinNYC2K17) May 19, 2018
New TSH limit of normality for pregnant women on the first trimester is 4.0 per new ATA 2017 guidelines based on a study done with >50000 women. Source: Dr. Elizabeth Pierce @TheAACE #AACE2018 #ClinicalEndoStrong
— Karyne Vinales (@KaryVinales) May 17, 2018
Critical treatment updates…
Novel Viral Insulin/IFG1 Like Peptides VILPs may turn out to be causative agents in many human diseases, e.g. type 1 diabetes #AACE2018 @TheAACE #type1diabetes #T1D pic.twitter.com/74I1I01VAk
— Patricia Wu (@PatriciaWu3) May 17, 2018
A new drug that can eliminate aging cells in different tissues #AACE2018 pic.twitter.com/OMHJ1Om3um
— Patricia Wu (@PatriciaWu3) May 19, 2018
Clinical trial shows improvement in PFS from 3.2 months to 12.1 months in patients with malignant adrenal gland tumors. #adcsm #AACE2018 #endcancer https://t.co/dywCs6Sl3L
— MD Anderson Cancer Center (@MDAndersonNews) May 21, 2018
Research for #T1D can help type 2 diabetic patients. #AACE2018 pic.twitter.com/Ql8ZiQNWpF
— Johnson Thomas (@JohnsonThomasMD) May 18, 2018
And plenty of noteworthy sessions.
Interesting talk about insulin action in brain #insulin #diabetes #AACE2018 pic.twitter.com/a2OpWRBhcc
— Aaron R.Chidakel, MD (@ACinNYC2K17) May 17, 2018
Still, speakers and attendees voiced the need for more research in particular areas.
"We need more studies in nutrition support," says Guillermo Umpierrez, MD, talking about glycemic control for non-ICU hospitalized patients. Just one 50-pt RCT, back in 2009. #AACE2018.
— Kari Oakes (@KariOakes) May 17, 2018
As usual, diabetes treatment was major topic of conversation at the meeting…
We are moving to time in target glucose range rather than A1c based on CGM #technology, via Dr. Hirsch. #diabetes #DigitalHealth #AACE2018
— Gregory Dodell, M.D. (@DodellMD) May 18, 2018
As was diet…
Quick take on some popular diets. #AACE2018 #nutrition pic.twitter.com/uHWAzCrYNX
— Armand Krikorian, MD (@ENDOUNO) May 18, 2018
…with a major nod toward nutrition.
Quick take on some popular diets. #AACE2018 #nutrition pic.twitter.com/uHWAzCrYNX
— Armand Krikorian, MD (@ENDOUNO) May 18, 2018
The technology surrounding these areas were another highlight.
Exciting new technology coming up soon in form of an app to help us with #insulindosing @TheAACE #AACE2018 #ClinicalEndoStrong @cmamillapalli pic.twitter.com/IZRLmuCNFb
— Karyne Vinales (@KaryVinales) May 19, 2018
That’s a wrap for AACE 2018! The 2019 annual meeting will be held in Los Angeles.
